UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have now determined the 3D structure of CCR2 simultaneously bound to two inhibitors. Understanding how these molecules fit together may better enable pharmaceutical companies to develop anti-inflammatory drugs that bind and inhibit CCR2 in a similar manner. The study is published December 7 by Nature.
Sponsored by the Veterans Affairs San Diego Healthcare System and UC San Diego, “So You Want To Be An Entrepreneur” will be held from 12:30 to 6:30 p.m. on Monday, Dec. 5, at Fuse Integration, 1425 E Street in downtown San Diego.
The Center for Energy Research (CER), an organized research unit at the University of California San Diego, will share a $13.5 million, three-year University of California grant to encourage collaboration between the UC campuses and the Lawrence Livermore, Los Alamos, and Lawrence Berkeley National Laboratories.
The fourth presentation in the Game Changers Series features Todd Hylton, a professor of practice at the UC San Diego Jacobs School of Engineering and executive director of the UC San Diego Contextual Robotics Institute.
The next presentation in UC San Diego’s “Inside Innovation” series features professors Andrew Kahn and Juan C. del Alamo discussing their latest research into quantifying a person’s risk for stroke through analyzing blood flow through the heart.
Biocom, the San Diego-based advocate for California’s life-science sector, has announced that the University of California San Diego has been named its “Community Partner of the Year” and will receive that recognition at the organization’s Annual Dinner on Nov. 17 at the La Jolla Hyatt Aventine.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
